High-Throughput Transcriptome Profiling Indicates Ribosomal RNAs to Be Associated with Resistance to Immunotherapy in Non-small Cell Lung Cancer (NSCLC)

Scientists used retrospective cohorts of immune checkpoint inhibitor treated patients with non-small cell lung cancer (NSCLC), to discover and validate spatially resolved protein markers associated with resistance to programmed cell death protein-1 axis inhibition.